Original Query: ALL
Previous Study | Return to List | Next Study

A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00091624
Recruitment Status : Completed
First Posted : September 15, 2004
Last Update Posted : December 1, 2016
Information provided by (Responsible Party):
Celgene Corporation